Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Etymax Ltd.

Etymax is a leading translation provider and language consultancy. We supply global language solutions to international companies across industry sectors, covering commercial, professional, technical and creative translations. Based in central London, we are at the hub of the global business world and are therefore ideally placed for the centralised coordination of multilingual materials. Our applied expertise in core industry terminologies helps businesses maximise their success across global markets through high quality translation, copy adaptation and all language related services.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Atlas Translations Ltd

With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…

View Profile

Translation services

Streaming Well - Video For Healthcare

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Medical communications, Medical education, Publishers, Translation services

Company Details

Etymax Ltd.
6 Bickels Yard, 151-153 Bermondsey Street, London, SE1 3HA, United Kingdom
+44 (0)20 7089 9098
Contact Etymax Ltd.
Website

 Latest Content from PMHub 

World-renowned creative icon Jeremy Perrott joins KVA

Press Releases | January 16, 2023 | KVA

KVA are excited to announce that Jeremy Perrott is joining the digital comms healthcare agency as a Board Advisor

Video: Strategic engagement case study

White Papers and Resources | January 13, 2023 | Inizio

Supporting the launch of a global vaccine with a programme of market research and strategic insights

Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

White Papers and Resources | January 13, 2023 | Inizio

Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.

Repurposing Off-Patent Drugs Through Crowd Funding

Videos and Podcasts | January 12, 2023 | Impetus Digital

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. 

The impact of mindset on digital product success: Download our new whitepaper

Press Releases | January 11, 2023 | Graphite Digital

Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...

SCIRIS ANNOUNCES APPOINTMENT OF NEW CEO

Press Releases | January 10, 2023 | Porterhouse Medical Group

Porterhouse extends a very warm welcome to Isaac Batley

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

White Papers and Resources | January 9, 2023 | Impetus Digital

It is no secret that Pharma (still) has a major diversity problem.

IGNIFI ANNOUNCES NEW LEADERSHIP TEAM FOR NEXT PHASE OF GROWTH

Press Releases | January 9, 2023 | IGNIFI

Creative healthcare marketing agency IGNIFI has announced its new senior leadership team, which includes the appointment of a new Managing Director for 2023 to lead the business into its next...

Research Partnership appoints new CEO

Press Releases | January 9, 2023 | Inizio

Research Partnership has appointed Gareth Phillips to take over as CEO

Intelligent and powerful Data/Publication Dissemination with Read, by QxMD

Videos and Podcasts | January 6, 2023 | Medscape Medical Affairs

You can get more information on QxMD Read here.  Or contact us directly to discuss here.